Author Question: The demand curve any monopolist uses in making output decisions is: a. the same as the demand curve ... (Read 53 times)

ghost!

  • Hero Member
  • *****
  • Posts: 560
The demand curve any monopolist uses in making output decisions is:
 a. the same as the demand curve facing a perfectly competitive firm.
  b. vertical, because there are no close substitutes for its product.
  c. horizontal, because there are no close substitutes for its product.
  d. the same as the market demand curve.
  e. perfectly inelastic.

Question 2

If the price of a product rises, consumers buy less of the good because the:
 a. MU/P of the good falls below the MU/P of other goods.
  b. MU/P of the good rises above the MU/P of other goods.
  c. marginal utility of the good diminishes.
  d. total utility of the good diminishes.
  e. marginal utility of the good rises.



macmac

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

d

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library